An investigational obesity drug from Eli Lilly cleared important end points in a late-stage trial, the company said Thursday, by helping patients lose up to 30 percent of their body weight. ...
Read more
As weary Americans hold out hope that the decline of Omicron signals an end to the pandemic’s emergency phase, physicians...
Read more
The resurgence of Ebola in central Africa is prompting international concern, with health officials issuing urgent warnings and travel restrictions...
Read moreThe Centers for Disease Control and Prevention (CDC) has expanded its enhanced Ebola screening to Hartsfield-Jackson Atlanta International Airport for...
Read moreThe Trump administration updated its travel restrictions amid the Ebola outbreak to temporarily include the entry of lawful permanent residents...
Read moreWorld Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus warned Friday that "violence and insecurity" have hampered the response to the...
Read moreThe head of the White House task force for the upcoming World Cup said Friday that the Democratic Republic of...
Read moreEpidemiologist Dr. Neil Vora warned that the spread of the Ebola virus in several African countries “will get worse before...
Read moreSen. Dick Durbin (D-Ill.) on Wednesday urged Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. to push back...
Read moreModerna’s experimental mRNA flu shot will be reviewed by a Food and Drug Administration advisory panel next month, a move...
Read moreAn investigational obesity drug from Eli Lilly cleared important end points in a late-stage trial, the company said Thursday, by helping patients lose up to 30 percent of their body weight. ...
Read moreThe White House on Thursday pushed back on reports that it resisted allowing an American physician who was exposed to...
Read more
